Theoharis Theoharides, PhD, MD

Theoharis C. Theoharides, PhD, MD is Professor of Pharmacology and Internal Medicine, as well as Director of Molecular Immunopharmacology and Drug Discovery, in the Department of Immunology at Tufts University School of Medicine, Boston, MA. He received all his degrees from Yale University (BA, MS, MPhil, PhD, MD) and was awarded the Dean’s Research Award and the Winternitz Price in Pathology.

Dr. Theoharides first showed that mast cells, known for causing allergic reactions, are critical for inflammation, especially in the brain, and are involved in a number of inflammatory conditions that worsen with stress such as allergies, asthma, autism spectrum disorder, eczema, fibromyalgia, interstitial cystitis/bladder pain syndrome, mast cell activation syndrome, migraines, multiple sclerosis, myalgic encephalomyelitis/ chronic fatigue syndrome and psoriasis.

He has published 450 scientific papers (JBC, JACI, JPET, NEJM, Nature, PNAS, Science) with 35,593 citations (h-factor 90) and 3 textbooks. He has been placed in the top 5% of authors most cited in pharmacological and immunological journals.

Dr. Theoharides is also the Scientific Director of Algonot, LLC and has helped formulate unique dietary supplements such as BrainGain, CystoProtek, FibroProtek, NeuroProtek, and PureLut and a skin lotionknown as GentleDerm containing the novel anti-inflammatory flavonoids, luteolin and tetramethoxyluteolin.

He has received 37 patents and trademarks, including some covering the use of luteolin in brain inflammation and autism: US 8,268,365 (09/18/12); US 9,050,275 (06/09/15); US 9,176,146 (11/03/15). He is President of the nonprofit company

Learn more: